Advertisement Solving Solubility: Eurand's Bioavailability Enhancement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

Solving Solubility: Eurand’s Bioavailability Enhancement

The insoluble nature of some compounds prevents the oral dosing of the treatments they enable. Innovation and precision engineering in equal measures have now overcome that problem, so that insolubility is no longer a barrier to oral delivery.